Significance of adenochoanal ratio and clinical score as diagnostic assessment for the adenoid hypertrophy
DOI:
https://doi.org/10.5457/ams.v41i2.281Keywords:
adenoid hypertrophy, adenochoanal ratio, clinical scoreAbstract
Abstract
Introduction: Chronic nasal obstruction in children is a very common disorder encountered in primary care and Ear, nose and throat [ENT] clinics. Obstructive adenoid has been implicated to be the major cause and is often the first to be blamed. It may be assessed by various tools, but there is a small consensus on their usefulness in diagnosis of adenoid hypertrophy.
Aim: The aim of this preliminary study is to determinate a significance of adenochoanal ratio [ACR] and clinical score [CS] for diagnostic assessment of adenoid hypertrophy.
Patients and methods: The study was conducted prospectively and encompassed 100 children, aged 35 - 170 months, consecutively admitted for tonsillectomy and tonsilloadenoidectomy. For all patients preoperationally we determined a CS and they were underwent rhinomanometry. Intraoperationally we determine ACR.
Results: One hundred patients aged 35 - 170 months, met the inclusion criteria. Significant relationship was found between diagnosis of admitted patients and ACR. Also, there were statistically significant correlation between ACR and CS. Correlation of CS with rhinomanometry was statistically analyzed with regression analysis. The P value was less than .001, showing significant relationship between them.
Conclusion: The CS suggested in our study, was devised relying on the most common symptoms encountered in patients with obstructive adenoid in the absence of other contributing pathologies. The strong correlation between the CS, ACR and rhinomanometry gives confidence in this score, especially that its predictive value based on that is very useful clinically.
Key words: adenoid hypertrophy, adenochoanal ratio, clinical score.
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
